BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Park KW, Wood CA, Li J, Taylor BC, Oh S, Young NL, Jankowsky JL. Gene therapy using Aβ variants for amyloid reduction. Mol Ther 2021;29:2294-307. [PMID: 33647457 DOI: 10.1016/j.ymthe.2021.02.026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 El Ganainy SO, Cijsouw T, Ali MA, Schoch S, Hanafy AS. Stereotaxic-assisted gene therapy in Alzheimer's and Parkinson's diseases: therapeutic potentials and clinical frontiers. Expert Rev Neurother 2022;:1-17. [PMID: 35319338 DOI: 10.1080/14737175.2022.2056446] [Reference Citation Analysis]
2 El-Battari A, Rodriguez L, Chahinian H, Delézay O, Fantini J, Yahi N, Di Scala C. Gene Therapy Strategy for Alzheimer's and Parkinson's Diseases Aimed at Preventing the Formation of Neurotoxic Oligomers in SH-SY5Y Cells. Int J Mol Sci 2021;22:11550. [PMID: 34768981 DOI: 10.3390/ijms222111550] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zhao R, Grunke SD, Li M, Wood CA, Perez GA, Comstock M, Singh AK, Park K, Jankowsky JL. Acute silencing uncovers multiple forms of activity-dependent neuronal survival in the mature entorhinal cortex.. [DOI: 10.1101/2021.10.18.464827] [Reference Citation Analysis]
4 Lennon MJ, Rigney G, Raymont V, Sachdev P. Genetic Therapies for Alzheimer's Disease: A Scoping Review. J Alzheimers Dis 2021;84:491-504. [PMID: 34569966 DOI: 10.3233/JAD-215145] [Cited by in F6Publishing: 1] [Reference Citation Analysis]